Novavax applies to WHO for emergency listing of COVID-19 vaccine

Novavax applies to WHO for emergency listing of COVID-19 vaccine
Novavax and its partner Serum Institute of India have applied to the World Health Organization for an emergency use listing of Novavax s COVID-19 vaccine, the company said on Thursday.

The WHO s emergency use listing is a signal to national regulatory authorities on a product s safety and efficacy.

It is also a prerequisite for export to several countries participating in the COVAX vaccine-sharing facility.

Novavax has said it would focus on low- and middle-income countries for initial supplies of the vaccine, as the United States and other Western nations have already vaccinated a large part of their populations with other vaccines.

Novavax had previously said it would apply for the listing in August, marking a slight delay in the filing.

Novavax and Serum Institute, the world s largest vaccine producer, have committed to together provide more than 1.1 billion doses to the COVAX facility, which aims to provide equitable access to COVID-19 vaccines to low- and middle-income countries.

The Novavax shot is a protein-based vaccine, and was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based clinical trial.
Read more on CTVnews
News Topics :
Similar Articles :
GENEVAJust a few weeks ago, the mood here at the headquarters of the World Health Organization WHO was still decidedly somber. WHO had pushed hard for equitable distribution of COVID 19...
GENEVA A leader of the U.N. backed program to ship COVID 19 vaccines to needy people in low and middle income countries expressed disappointment on Friday about supply delays from a key...
GENEVA It’s nearly launch time for COVAX, the United Nations’ unprecedented program to deploy COVID 19 vaccines for hundreds of millions in need around the globe. More than two months...
GENEVA Moderna and vaccine promoter Gavi have announced a deal by which the pharmaceutical company will provide up to 500 million doses for the U.N. backed program to ship coronavirus...
TAIPEI, Taiwan China on Wednesday announced a plan to provide 10 million coronavirus vaccine doses to developing nations through the global COVAX initiative as part of its ambitious diplomatic...